Table 2 miRNA transcripts displaying a significant differential expression in patients with lung cancer compared to control patients.

From: EV-associated miRNAs from pleural lavage as potential diagnostic biomarkers in lung cancer

ID

logFC

P-Value

adj.P-Va

hsa-miR-150-5p_477918_mir

3,65

1,87E-03

3,91E-02

hsa-miR-144-5p_477914_mir

−11,37

3,76E-04

1,28E-02

hsa-miR-1-3p_477820_mir

−13,78

1,41E-06

1,92E-04

hsa-miR-584-5p_478167_mir

−9,55

1,90E-08

5,17E-06

hsa-miR-133b_480871_mir

−7,72

1,30E-03

3,52E-02

hsa-miR-451a_478107_mir

−3,29

3,50E-04

1,28E-02

hsa-miR-27a-5p_477998_mir

4,93

8,05E-05

7,30E-03

hsa-miR-21-3p_477973_mir

5,65

1,99E-04

1,28E-02

hsa-miR-199a-5p_478231_mir

−7,73

3,47E-04

1,28E-02

hsa-miR-1249-3p_478654_mir

6,70

5,62E-04

1,70E-02

hsa-miR-485-3p_478125_mir

4,80

1,82E-03

3,91E-02

hsa-miR-20b-5p_477804_mir

−8,18

3,05E-04

1,28E-02

hsa-miR-181c-5p_477934_mir

−3,79

2,06E-03

4,01E-02

hsa-miR-30e-5p_479235_mir

−6,46

1,45E-03

3,59E-02

  1. Log fold-change expression, p-value and adjusted p-value of the 14 miRNAs significantly dysregulated in EVs from the pleural lavage of lung cancer patients compared to control (adj. p-value < 0.05 and logFC lower or higher than 3).